CellPharmer, LLC is a start-up company dedicated to bringing to the market human cultured red blood cells produced from stem cells using an innovative technology. 

 Our first application will be the production of a panel of reagent red blood cells specifically designed to help the identification of allo-antibodies in sickle disease patients.

Our second application will be the development of red blood cells carrying rare blood groups for transfusion support of allo-immunized sickle cell disease patients.